MEG3 and ovarian carcinoma: Therefore, the aim of this study is to further explore of mechanisms underlying the role of MEG3 expression levels on anti-cancer effects of DNC, OXA and combination treatment, via meditating MMP-2 and MMP-9 involved in tumor cell invasion and metastasis in OVCAR3 and SKOV3 ovarian cancer cell lines.